Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Dietary crossover challenge of gluten, inulin, and amylase trypsin inhibitors in irritable bowel syndrome patients

FY 2017-18

Summary
Irritable bowel syndrome (IBS) is a gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits. It affects over 5 million Canadians and is the primary reason for gastroenterologist referrals, producing an economic burden of over $6.5 billion per year. Wheat is commonly considered to trigger IBS symptoms; however, the mechanism is not yet understood. Possible culprits include the wheat components gluten, inulin, and amylase-trypsin inhibitors (ATIs). Gluten has been shown to induce intestinal and extra-intestinal symptoms in a subgroup of IBS patients with a genetic predisposition to celiac disease. Inulin may cause bloating by increasing gut bacteria fermentation. ATIs may also contribute to IBS symptoms by activating the innate immune system. However, it is unknown which specific wheat components are responsible in different IBS subgroups. Therefore, a double-blinded randomized controlled crossover trial was designed to separate their effects. Participants from the McMaster Digestive Diseases Clinic will be put on a gluten-free diet and randomized to receive four different treatments in a period of 10 weeks: 7 days of either gluten, ATIs, inulin, or placebo followed by a washout period for 10 days and then repeated for each of the other treatments. This study will evaluate the effects and potential mechanisms of gluten, inulin, and ATIs on intestinal and extra-intestinal symptoms in IBS. It is likely that different wheat components induce symptoms in different IBS subgroups, thus, our project may lead to better diagnosis and individualized dietary treatments for IBS.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
387205
Name
Seiler Caroline
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Dietary crossover challenge of gluten, inulin, and amylase trypsin inhibitors in irritable bowel syndrome patients
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Amylase Trypin Inhibitors; Crossover; Fodmaps; Gastrointestinal Symptoms; Gliadin; Gluten; Gluten Free Diet; Inulin; Irritable Bowel Syndrome (Ibs); Non-Celiac Gluten/Wheat Sensitivity
Abstract
Irritable bowel syndrome (IBS) is a gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits. It affects over 5 million Canadians and is the primary reason for gastroenterologist referrals, producing an economic burden of over $6.5 billion per year. Wheat is commonly considered to trigger IBS symptoms; however, the mechanism is not yet understood. Possible culprits include the wheat components gluten, inulin, and amylase-trypsin inhibitors (ATIs). Gluten has been shown to induce intestinal and extra-intestinal symptoms in a subgroup of IBS patients with a genetic predisposition to celiac disease. Inulin may cause bloating by increasing gut bacteria fermentation. ATIs may also contribute to IBS symptoms by activating the innate immune system. However, it is unknown which specific wheat components are responsible in different IBS subgroups. Therefore, a double-blinded randomized controlled crossover trial was designed to separate their effects. Participants from the McMaster Digestive Diseases Clinic will be put on a gluten-free diet and randomized to receive four different treatments in a period of 10 weeks: 7 days of either gluten, ATIs, inulin, or placebo followed by a washout period for 10 days and then repeated for each of the other treatments. This study will evaluate the effects and potential mechanisms of gluten, inulin, and ATIs on intestinal and extra-intestinal symptoms in IBS. It is likely that different wheat components induce symptoms in different IBS subgroups, thus, our project may lead to better diagnosis and individualized dietary treatments for IBS.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Seiler, Caroline
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~